| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |